StocksMediumUpdated•Originally published 30 September 2026•Updated 30 September 2026•
1 min read
Liquidia Shares Plunge Following Adverse Patent Ruling in United Therapeutics Dispute
Key Facts
1Liquidia shares dropped significantly following a court ruling in a patent dispute with United Therapeutics.
Liquidia Corporation shares plummeted 48% and saw a surge in options activity following a court ruling in a patent dispute with United Therapeutics. Reuters reported that Judge Richard G. Andrews denied Liquidia's motion to strike, a decision that triggered a massive sell-off in the stock.
LQDA closed at $70.69 on September 29, 2026, as the legal setback weakened its competitive outlook. Meanwhile, United Therapeutics (UTHR) shares closed at $481.47 on September 29, 2026.